{
  "cells": [
    {
      "cell_type": "markdown",
      "id": "e9656b57-fbf4-4aaa-a131-f2f2006a58be",
      "metadata": {
        "id": "e9656b57-fbf4-4aaa-a131-f2f2006a58be"
      },
      "source": [
        "# Analyzing the Impact of Ascites and D-Penicillamine on Mortality in Primary Biliary Cirrhosis Patients: A Statistical Inference Study\n",
        "#### Authors: Hrishi Logani, Rithika Nair, Yuexiang Ni, Yuxi Zhang (Group 43)"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "83527891-e9bd-4b2e-b749-2f1d4c0caae1",
      "metadata": {
        "id": "83527891-e9bd-4b2e-b749-2f1d4c0caae1"
      },
      "source": [
        "## Introduction"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "6d0a2c47-6444-40fe-8fb0-a09e70c3527f",
      "metadata": {
        "id": "6d0a2c47-6444-40fe-8fb0-a09e70c3527f"
      },
      "source": [
        "Primary biliary cirrhosis (PBC) is a chronic condition characterized by gradual damage and deterioration of the liver's bile ducts, leading to substantial liver-related health challenges. PBC stands as a prominent contributor to liver-related illnesses and fatalities. The prognosis of PBC is influenced by multiple factors critical to effective treatment (Prince et al., 2002). Notably, advanced PBC often manifests the complication of ascites, characterized by an accumulation of fluid in the abdominal cavity (Purohit, 2015). This project endeavors to examine how ascites impacts the prognosis of patients receiving D-penicillamine. It's worth noting that the effectiveness of D-penicillamine remains uncertain (Purohit, 2015). We chose to analyze this to improve patient treatment insights. Thus, we are asking the following question:\n",
        "\n",
        "#### For Primary Biliary Cirrhosis patients administered with D-Penicillamine, does the presence of Ascites determine their mortality?\n",
        "\n",
        "To investigate this, we shall analyze the difference in mortality rate based on the following categorical variables and the scale parameter will be a standard error of proportions.\n",
        "\n",
        "* Type of treatment (D-penicillamine or Placebo)\n",
        "* Presence of Ascites\n",
        "\n",
        "The analysis will focus on comparing proportions, as both \"Drug\" type and \"Ascites\" presence have only two discrete outcomes. Standard error will be used to quantify the statistic's variation from the population proportion. This project seeks to provide insights into the impact of \"Ascites\" on the prognosis of PBC patients treated with \"D-penicillamine,\" using a comprehensive dataset for a thorough investigation.\n",
        "\n",
        "The dataset used is the __[Cirrhosis Patient Survival Prediction](https://archive.ics.uci.edu/dataset/878/cirrhosis+patient+survival+prediction+dataset-1)__ dataset from the UCI Machine Learning Repository, containing information on 418 PBC patients. Each patient's data includes unique identifiers (\"ID\"), days between registration (\"N_Days\"), patient status (\"Status\"), drug type (\"Drug\"), age (\"Age\"), sex (\"Sex\"), and various clinical parameters."
      ]
    },
    {
      "cell_type": "markdown",
      "id": "Ylv7bYTLUwe8",
      "metadata": {
        "id": "Ylv7bYTLUwe8"
      },
      "source": [
        "## Methods & Results"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "6f7be9c0-afb4-466c-a657-e05a95e915b9",
      "metadata": {
        "id": "6f7be9c0-afb4-466c-a657-e05a95e915b9"
      },
      "source": [
        "### Loading Necessary Libraries"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 7,
      "id": "a177901e-04ae-448f-9b48-faad9b98056c",
      "metadata": {
        "id": "a177901e-04ae-448f-9b48-faad9b98056c"
      },
      "outputs": [],
      "source": [
        "library(tidyverse)\n",
        "library(broom)\n",
        "library(repr)\n",
        "library(digest)\n",
        "library(infer)\n",
        "library(gridExtra)"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "01ddd584-ec3c-4dfd-aaa3-11552466b61e",
      "metadata": {
        "id": "01ddd584-ec3c-4dfd-aaa3-11552466b61e"
      },
      "source": [
        "### Downloading Dataset from the Web"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "73b8908e-7867-4358-8744-1b24588a5290",
      "metadata": {
        "id": "73b8908e-7867-4358-8744-1b24588a5290"
      },
      "source": [
        "Downloading the dataset that is stored in a public repository."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 8,
      "id": "399a1163-a952-441b-b5a5-26d71f2ffb69",
      "metadata": {
        "id": "399a1163-a952-441b-b5a5-26d71f2ffb69",
        "outputId": "c67826f2-01bd-424b-b676-e6ae1ad3d083",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 376
        }
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "<table class=\"dataframe\">\n",
              "<caption>A data.frame: 6 × 20</caption>\n",
              "<thead>\n",
              "\t<tr><th></th><th scope=col>ID</th><th scope=col>N_Days</th><th scope=col>Status</th><th scope=col>Drug</th><th scope=col>Age</th><th scope=col>Sex</th><th scope=col>Ascites</th><th scope=col>Hepatomegaly</th><th scope=col>Spiders</th><th scope=col>Edema</th><th scope=col>Bilirubin</th><th scope=col>Cholesterol</th><th scope=col>Albumin</th><th scope=col>Copper</th><th scope=col>Alk_Phos</th><th scope=col>SGOT</th><th scope=col>Tryglicerides</th><th scope=col>Platelets</th><th scope=col>Prothrombin</th><th scope=col>Stage</th></tr>\n",
              "\t<tr><th></th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n",
              "</thead>\n",
              "<tbody>\n",
              "\t<tr><th scope=row>1</th><td>1</td><td> 400</td><td>D </td><td>D-penicillamine</td><td>21464</td><td>F</td><td>Y</td><td>Y</td><td>Y</td><td>Y</td><td>14.5</td><td>261</td><td>2.60</td><td>156</td><td>1718.0</td><td>137.95</td><td>172</td><td>190</td><td>12.2</td><td>4</td></tr>\n",
              "\t<tr><th scope=row>2</th><td>2</td><td>4500</td><td>C </td><td>D-penicillamine</td><td>20617</td><td>F</td><td>N</td><td>Y</td><td>Y</td><td>N</td><td> 1.1</td><td>302</td><td>4.14</td><td> 54</td><td>7394.8</td><td>113.52</td><td> 88</td><td>221</td><td>10.6</td><td>3</td></tr>\n",
              "\t<tr><th scope=row>3</th><td>3</td><td>1012</td><td>D </td><td>D-penicillamine</td><td>25594</td><td>M</td><td>N</td><td>N</td><td>N</td><td>S</td><td> 1.4</td><td>176</td><td>3.48</td><td>210</td><td> 516.0</td><td> 96.10</td><td> 55</td><td>151</td><td>12.0</td><td>4</td></tr>\n",
              "\t<tr><th scope=row>4</th><td>4</td><td>1925</td><td>D </td><td>D-penicillamine</td><td>19994</td><td>F</td><td>N</td><td>Y</td><td>Y</td><td>S</td><td> 1.8</td><td>244</td><td>2.54</td><td> 64</td><td>6121.8</td><td> 60.63</td><td> 92</td><td>183</td><td>10.3</td><td>4</td></tr>\n",
              "\t<tr><th scope=row>5</th><td>5</td><td>1504</td><td>CL</td><td>Placebo        </td><td>13918</td><td>F</td><td>N</td><td>Y</td><td>Y</td><td>N</td><td> 3.4</td><td>279</td><td>3.53</td><td>143</td><td> 671.0</td><td>113.15</td><td> 72</td><td>136</td><td>10.9</td><td>3</td></tr>\n",
              "\t<tr><th scope=row>6</th><td>6</td><td>2503</td><td>D </td><td>Placebo        </td><td>24201</td><td>F</td><td>N</td><td>Y</td><td>N</td><td>N</td><td> 0.8</td><td>248</td><td>3.98</td><td> 50</td><td> 944.0</td><td> 93.00</td><td> 63</td><td> NA</td><td>11.0</td><td>3</td></tr>\n",
              "</tbody>\n",
              "</table>\n"
            ],
            "text/markdown": "\nA data.frame: 6 × 20\n\n| <!--/--> | ID &lt;int&gt; | N_Days &lt;int&gt; | Status &lt;chr&gt; | Drug &lt;chr&gt; | Age &lt;int&gt; | Sex &lt;chr&gt; | Ascites &lt;chr&gt; | Hepatomegaly &lt;chr&gt; | Spiders &lt;chr&gt; | Edema &lt;chr&gt; | Bilirubin &lt;dbl&gt; | Cholesterol &lt;int&gt; | Albumin &lt;dbl&gt; | Copper &lt;int&gt; | Alk_Phos &lt;dbl&gt; | SGOT &lt;dbl&gt; | Tryglicerides &lt;int&gt; | Platelets &lt;int&gt; | Prothrombin &lt;dbl&gt; | Stage &lt;int&gt; |\n|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n| 1 | 1 |  400 | D  | D-penicillamine | 21464 | F | Y | Y | Y | Y | 14.5 | 261 | 2.60 | 156 | 1718.0 | 137.95 | 172 | 190 | 12.2 | 4 |\n| 2 | 2 | 4500 | C  | D-penicillamine | 20617 | F | N | Y | Y | N |  1.1 | 302 | 4.14 |  54 | 7394.8 | 113.52 |  88 | 221 | 10.6 | 3 |\n| 3 | 3 | 1012 | D  | D-penicillamine | 25594 | M | N | N | N | S |  1.4 | 176 | 3.48 | 210 |  516.0 |  96.10 |  55 | 151 | 12.0 | 4 |\n| 4 | 4 | 1925 | D  | D-penicillamine | 19994 | F | N | Y | Y | S |  1.8 | 244 | 2.54 |  64 | 6121.8 |  60.63 |  92 | 183 | 10.3 | 4 |\n| 5 | 5 | 1504 | CL | Placebo         | 13918 | F | N | Y | Y | N |  3.4 | 279 | 3.53 | 143 |  671.0 | 113.15 |  72 | 136 | 10.9 | 3 |\n| 6 | 6 | 2503 | D  | Placebo         | 24201 | F | N | Y | N | N |  0.8 | 248 | 3.98 |  50 |  944.0 |  93.00 |  63 |  NA | 11.0 | 3 |\n\n",
            "text/latex": "A data.frame: 6 × 20\n\\begin{tabular}{r|llllllllllllllllllll}\n  & ID & N\\_Days & Status & Drug & Age & Sex & Ascites & Hepatomegaly & Spiders & Edema & Bilirubin & Cholesterol & Albumin & Copper & Alk\\_Phos & SGOT & Tryglicerides & Platelets & Prothrombin & Stage\\\\\n  & <int> & <int> & <chr> & <chr> & <int> & <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <int> & <dbl> & <int> & <dbl> & <dbl> & <int> & <int> & <dbl> & <int>\\\\\n\\hline\n\t1 & 1 &  400 & D  & D-penicillamine & 21464 & F & Y & Y & Y & Y & 14.5 & 261 & 2.60 & 156 & 1718.0 & 137.95 & 172 & 190 & 12.2 & 4\\\\\n\t2 & 2 & 4500 & C  & D-penicillamine & 20617 & F & N & Y & Y & N &  1.1 & 302 & 4.14 &  54 & 7394.8 & 113.52 &  88 & 221 & 10.6 & 3\\\\\n\t3 & 3 & 1012 & D  & D-penicillamine & 25594 & M & N & N & N & S &  1.4 & 176 & 3.48 & 210 &  516.0 &  96.10 &  55 & 151 & 12.0 & 4\\\\\n\t4 & 4 & 1925 & D  & D-penicillamine & 19994 & F & N & Y & Y & S &  1.8 & 244 & 2.54 &  64 & 6121.8 &  60.63 &  92 & 183 & 10.3 & 4\\\\\n\t5 & 5 & 1504 & CL & Placebo         & 13918 & F & N & Y & Y & N &  3.4 & 279 & 3.53 & 143 &  671.0 & 113.15 &  72 & 136 & 10.9 & 3\\\\\n\t6 & 6 & 2503 & D  & Placebo         & 24201 & F & N & Y & N & N &  0.8 & 248 & 3.98 &  50 &  944.0 &  93.00 &  63 &  NA & 11.0 & 3\\\\\n\\end{tabular}\n",
            "text/plain": [
              "  ID N_Days Status Drug            Age   Sex Ascites Hepatomegaly Spiders Edema\n",
              "1 1   400   D      D-penicillamine 21464 F   Y       Y            Y       Y    \n",
              "2 2  4500   C      D-penicillamine 20617 F   N       Y            Y       N    \n",
              "3 3  1012   D      D-penicillamine 25594 M   N       N            N       S    \n",
              "4 4  1925   D      D-penicillamine 19994 F   N       Y            Y       S    \n",
              "5 5  1504   CL     Placebo         13918 F   N       Y            Y       N    \n",
              "6 6  2503   D      Placebo         24201 F   N       Y            N       N    \n",
              "  Bilirubin Cholesterol Albumin Copper Alk_Phos SGOT   Tryglicerides Platelets\n",
              "1 14.5      261         2.60    156    1718.0   137.95 172           190      \n",
              "2  1.1      302         4.14     54    7394.8   113.52  88           221      \n",
              "3  1.4      176         3.48    210     516.0    96.10  55           151      \n",
              "4  1.8      244         2.54     64    6121.8    60.63  92           183      \n",
              "5  3.4      279         3.53    143     671.0   113.15  72           136      \n",
              "6  0.8      248         3.98     50     944.0    93.00  63            NA      \n",
              "  Prothrombin Stage\n",
              "1 12.2        4    \n",
              "2 10.6        3    \n",
              "3 12.0        4    \n",
              "4 10.3        4    \n",
              "5 10.9        3    \n",
              "6 11.0        3    "
            ]
          },
          "metadata": {}
        }
      ],
      "source": [
        "# URL containing the dataset\n",
        "url <- \"https://raw.githubusercontent.com/Rithika-Nair/STAT-201-Final_Project/main/cirrhosis.csv\"\n",
        "\n",
        "# Download cirrhosis.csv from the url\n",
        "download.file(url, \"cirrhosis.csv\")\n",
        "\n",
        "# Store the dataset into variable\n",
        "cirr_data <- read.csv(\"cirrhosis.csv\")\n",
        "\n",
        "# Display the first few rows of the dataset\n",
        "head(cirr_data)"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "3115bef7-fe87-41e2-b1c3-83769486fef1",
      "metadata": {
        "id": "3115bef7-fe87-41e2-b1c3-83769486fef1"
      },
      "source": [
        "### Data Cleaning and Preprocessing"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "a88844e6-4d1a-4782-90de-c12419673715",
      "metadata": {
        "id": "a88844e6-4d1a-4782-90de-c12419673715"
      },
      "source": [
        "Selecting columns relevant to our analysis: `Status`, `Drug`, `Ascites`."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 9,
      "id": "b5a698c5-9adc-46b3-bd19-131ca71f930b",
      "metadata": {
        "id": "b5a698c5-9adc-46b3-bd19-131ca71f930b",
        "outputId": "454db681-870b-4c80-f076-e44ed638fbc3",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 304
        }
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "<table class=\"dataframe\">\n",
              "<caption>A data.frame: 6 × 3</caption>\n",
              "<thead>\n",
              "\t<tr><th></th><th scope=col>Status</th><th scope=col>Drug</th><th scope=col>Ascites</th></tr>\n",
              "\t<tr><th></th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n",
              "</thead>\n",
              "<tbody>\n",
              "\t<tr><th scope=row>1</th><td>D </td><td>D-penicillamine</td><td>Y</td></tr>\n",
              "\t<tr><th scope=row>2</th><td>C </td><td>D-penicillamine</td><td>N</td></tr>\n",
              "\t<tr><th scope=row>3</th><td>D </td><td>D-penicillamine</td><td>N</td></tr>\n",
              "\t<tr><th scope=row>4</th><td>D </td><td>D-penicillamine</td><td>N</td></tr>\n",
              "\t<tr><th scope=row>5</th><td>CL</td><td>Placebo        </td><td>N</td></tr>\n",
              "\t<tr><th scope=row>6</th><td>D </td><td>Placebo        </td><td>N</td></tr>\n",
              "</tbody>\n",
              "</table>\n"
            ],
            "text/markdown": "\nA data.frame: 6 × 3\n\n| <!--/--> | Status &lt;chr&gt; | Drug &lt;chr&gt; | Ascites &lt;chr&gt; |\n|---|---|---|---|\n| 1 | D  | D-penicillamine | Y |\n| 2 | C  | D-penicillamine | N |\n| 3 | D  | D-penicillamine | N |\n| 4 | D  | D-penicillamine | N |\n| 5 | CL | Placebo         | N |\n| 6 | D  | Placebo         | N |\n\n",
            "text/latex": "A data.frame: 6 × 3\n\\begin{tabular}{r|lll}\n  & Status & Drug & Ascites\\\\\n  & <chr> & <chr> & <chr>\\\\\n\\hline\n\t1 & D  & D-penicillamine & Y\\\\\n\t2 & C  & D-penicillamine & N\\\\\n\t3 & D  & D-penicillamine & N\\\\\n\t4 & D  & D-penicillamine & N\\\\\n\t5 & CL & Placebo         & N\\\\\n\t6 & D  & Placebo         & N\\\\\n\\end{tabular}\n",
            "text/plain": [
              "  Status Drug            Ascites\n",
              "1 D      D-penicillamine Y      \n",
              "2 C      D-penicillamine N      \n",
              "3 D      D-penicillamine N      \n",
              "4 D      D-penicillamine N      \n",
              "5 CL     Placebo         N      \n",
              "6 D      Placebo         N      "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "418"
            ],
            "text/markdown": "418",
            "text/latex": "418",
            "text/plain": [
              "[1] 418"
            ]
          },
          "metadata": {}
        }
      ],
      "source": [
        "cirrhosis <- cirr_data %>%\n",
        "        select(Status, Drug, Ascites)\n",
        "\n",
        "head(cirrhosis)\n",
        "nrow(cirrhosis)"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "1d365a80-cf35-4e5f-8fef-e20c6a3dc8d0",
      "metadata": {
        "id": "1d365a80-cf35-4e5f-8fef-e20c6a3dc8d0"
      },
      "source": [
        "Checking for missing values in each of the columns and removing the rows that contain missing values."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 10,
      "id": "f085b3e2-d0b3-4dfb-82b7-9f131d02954c",
      "metadata": {
        "id": "f085b3e2-d0b3-4dfb-82b7-9f131d02954c",
        "outputId": "412cdd2e-5650-4e8c-9ddd-0f2011f4005e",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[1] 0\n",
            "[1] 106\n",
            "[1] 106\n"
          ]
        }
      ],
      "source": [
        "# Printing the number of missing values in each column\n",
        "print(sum(is.na(cirrhosis$Status)))\n",
        "print(sum(is.na(cirrhosis$Drug)))\n",
        "print(sum(is.na(cirrhosis$Ascites)))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 14,
      "id": "1dd5a118-8851-483b-8c06-7d0daa2c7121",
      "metadata": {
        "id": "1dd5a118-8851-483b-8c06-7d0daa2c7121",
        "outputId": "c87af515-f5c8-46ea-a3c1-d7b0afe59745",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 304
        }
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "<table class=\"dataframe\">\n",
              "<caption>A data.frame: 6 × 3</caption>\n",
              "<thead>\n",
              "\t<tr><th></th><th scope=col>Status</th><th scope=col>Drug</th><th scope=col>Ascites</th></tr>\n",
              "\t<tr><th></th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n",
              "</thead>\n",
              "<tbody>\n",
              "\t<tr><th scope=row>1</th><td>D </td><td>D-penicillamine</td><td>Y</td></tr>\n",
              "\t<tr><th scope=row>2</th><td>D </td><td>D-penicillamine</td><td>N</td></tr>\n",
              "\t<tr><th scope=row>3</th><td>D </td><td>D-penicillamine</td><td>N</td></tr>\n",
              "\t<tr><th scope=row>4</th><td>CL</td><td>Placebo        </td><td>N</td></tr>\n",
              "\t<tr><th scope=row>5</th><td>D </td><td>Placebo        </td><td>N</td></tr>\n",
              "\t<tr><th scope=row>6</th><td>D </td><td>Placebo        </td><td>N</td></tr>\n",
              "</tbody>\n",
              "</table>\n"
            ],
            "text/markdown": "\nA data.frame: 6 × 3\n\n| <!--/--> | Status &lt;chr&gt; | Drug &lt;chr&gt; | Ascites &lt;chr&gt; |\n|---|---|---|---|\n| 1 | D  | D-penicillamine | Y |\n| 2 | D  | D-penicillamine | N |\n| 3 | D  | D-penicillamine | N |\n| 4 | CL | Placebo         | N |\n| 5 | D  | Placebo         | N |\n| 6 | D  | Placebo         | N |\n\n",
            "text/latex": "A data.frame: 6 × 3\n\\begin{tabular}{r|lll}\n  & Status & Drug & Ascites\\\\\n  & <chr> & <chr> & <chr>\\\\\n\\hline\n\t1 & D  & D-penicillamine & Y\\\\\n\t2 & D  & D-penicillamine & N\\\\\n\t3 & D  & D-penicillamine & N\\\\\n\t4 & CL & Placebo         & N\\\\\n\t5 & D  & Placebo         & N\\\\\n\t6 & D  & Placebo         & N\\\\\n\\end{tabular}\n",
            "text/plain": [
              "  Status Drug            Ascites\n",
              "1 D      D-penicillamine Y      \n",
              "2 D      D-penicillamine N      \n",
              "3 D      D-penicillamine N      \n",
              "4 CL     Placebo         N      \n",
              "5 D      Placebo         N      \n",
              "6 D      Placebo         N      "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "144"
            ],
            "text/markdown": "144",
            "text/latex": "144",
            "text/plain": [
              "[1] 144"
            ]
          },
          "metadata": {}
        }
      ],
      "source": [
        "# Filtering out the rows containing NA values in either Drug or Ascites columns\n",
        "cirrhosis_filtered <- cirrhosis %>%\n",
        "        filter(!is.na(Drug)) %>%\n",
        "        filter(!is.na(Ascites)) %>%\n",
        "        filter(Status %in% c(\"CL\", \"D\"))\n",
        "\n",
        "head(cirrhosis_filtered)\n",
        "nrow(cirrhosis_filtered)"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Exploratory data analysis\n",
        "\n",
        "\n",
        "*   We shall conduct our analysis by grouping the patients into 2 different classes based on the administration of D-Pencilamine and presence of ascites.\n",
        "\n",
        "\n"
      ],
      "metadata": {
        "id": "f3gZXd7eAi9W"
      },
      "id": "f3gZXd7eAi9W"
    },
    {
      "cell_type": "markdown",
      "source": [
        "### **Hypothesis Testing**\n",
        "\n",
        "The estimates produced in the previous section are not sufficient as there is no metion of the statistical significance of the evidence. Therefore, we will need to perform hypothesis testing to determine the reliability of our conlustion. We plan to support our data by testing the following hypothesis:\n",
        "\n",
        "*   $ H_0 : p_1 - p_2 = 0$\n",
        "*   $ H_1 : p_1 - p_2 \\neq 0$\n",
        "\n",
        "\n",
        "\n",
        "Here, $p_1$ denotes the proportion of patients administered with D-penicillamine and Ascites who died, while $p_2$ represents the proportion of patients administered with D-penicillamine without ascites but still died. The objective is to rigorously assess the statistical evidence supporting our conclusions.\n",
        "The null hypothesis states that the difference in mortality rates between patients administered with D-penicillamine and Ascites ($p_1$) and those administered with D-penicillamine without ascites ($p_2$) who died is zero whereas the alternative hypothesis statest that there is a difference between mortality rates between the two groups.\n",
        "\n",
        "We have chosen a significance level of $α=0.05$ for our hypothesis testing, striking a balance between the probabilities of type 1 and type 2 errors. Opting for a lower significance level would elevate the risk of committing a type 2 error, which, in this context, is more consequential than a type 1 error. A type 2 error would imply the erroneous conclusion that there is no difference in mortality rates when, in fact, there is. Conversely, increasing the significance level would necessitate stronger evidence to reach a statistically significant conclusion. Hence, our selected significance level aligns with the objective of minimizing both types of errors while maintaining a practical balance.\n",
        "\n"
      ],
      "metadata": {
        "id": "hrQM6_3fEAVA"
      },
      "id": "hrQM6_3fEAVA"
    },
    {
      "cell_type": "markdown",
      "source": [
        "### **Creating the null model**\n",
        "*   Now, we shall calculate the summary statistic and make a null distribution using the infer package.\n"
      ],
      "metadata": {
        "id": "NQF6sJ_xJOeO"
      },
      "id": "NQF6sJ_xJOeO"
    },
    {
      "cell_type": "code",
      "execution_count": 25,
      "id": "49cc97fd-2cd5-4c40-bb15-fdf443bcfbc6",
      "metadata": {
        "id": "49cc97fd-2cd5-4c40-bb15-fdf443bcfbc6",
        "outputId": "4aa330fa-4e37-41a5-8d2b-29e56b3db162",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 286
        }
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "<table class=\"dataframe\">\n",
              "<caption>A infer: 6 × 2</caption>\n",
              "<thead>\n",
              "\t<tr><th scope=col>replicate</th><th scope=col>stat</th></tr>\n",
              "\t<tr><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th></tr>\n",
              "</thead>\n",
              "<tbody>\n",
              "\t<tr><td>1</td><td>-0.02481390</td></tr>\n",
              "\t<tr><td>2</td><td> 0.06823821</td></tr>\n",
              "\t<tr><td>3</td><td> 0.16129032</td></tr>\n",
              "\t<tr><td>4</td><td> 0.06823821</td></tr>\n",
              "\t<tr><td>5</td><td>-0.11786600</td></tr>\n",
              "\t<tr><td>6</td><td> 0.16129032</td></tr>\n",
              "</tbody>\n",
              "</table>\n"
            ],
            "text/markdown": "\nA infer: 6 × 2\n\n| replicate &lt;int&gt; | stat &lt;dbl&gt; |\n|---|---|\n| 1 | -0.02481390 |\n| 2 |  0.06823821 |\n| 3 |  0.16129032 |\n| 4 |  0.06823821 |\n| 5 | -0.11786600 |\n| 6 |  0.16129032 |\n\n",
            "text/latex": "A infer: 6 × 2\n\\begin{tabular}{ll}\n replicate & stat\\\\\n <int> & <dbl>\\\\\n\\hline\n\t 1 & -0.02481390\\\\\n\t 2 &  0.06823821\\\\\n\t 3 &  0.16129032\\\\\n\t 4 &  0.06823821\\\\\n\t 5 & -0.11786600\\\\\n\t 6 &  0.16129032\\\\\n\\end{tabular}\n",
            "text/plain": [
              "  replicate stat       \n",
              "1 1         -0.02481390\n",
              "2 2          0.06823821\n",
              "3 3          0.16129032\n",
              "4 4          0.06823821\n",
              "5 5         -0.11786600\n",
              "6 6          0.16129032"
            ]
          },
          "metadata": {}
        }
      ],
      "source": [
        "# set seed to ensure that data is reproducible\n",
        "set.seed(69)\n",
        "\n",
        "# create the null distribution\n",
        "null_distribution <- cirrhosis_filtered |> filter(Drug == \"D-penicillamine\") |>\n",
        "                     specify(formula = Status ~ Ascites, success = \"D\") |>\n",
        "                     hypothesize(null=\"independence\") |>\n",
        "                     generate(reps = 10000, type = \"permute\") |>\n",
        "                     calculate(stat = \"diff in props\", order = c(\"Y\", \"N\"))\n",
        "\n",
        "head(null_distribution)\n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Table <No> : 1000 samples taken from the Null Model using the infer package"
      ],
      "metadata": {
        "id": "qmEIS5ASMr49"
      },
      "id": "qmEIS5ASMr49"
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Calculating test statistic\n",
        "\n",
        "\n",
        "*  Now, we shall calculate the observed difference in mortality rates using infer package.\n",
        "\n"
      ],
      "metadata": {
        "id": "lcRRdAjsNF13"
      },
      "id": "lcRRdAjsNF13"
    },
    {
      "cell_type": "code",
      "source": [
        "obs_diff_prop <- cirrhosis_filtered |> filter(Drug == \"D-penicillamine\") |>\n",
        "                 specify(Status ~ Ascites, success = \"D\") |>\n",
        "                 calculate(stat = \"diff in props\", order = c(\"Y\", \"N\"))\n",
        "obs_diff_prop"
      ],
      "metadata": {
        "id": "zM5V2FFxNXUF",
        "outputId": "a0481664-8c54-42de-d89e-9d4532f9d8a5",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 129
        }
      },
      "id": "zM5V2FFxNXUF",
      "execution_count": 26,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "<table class=\"dataframe\">\n",
              "<caption>A infer: 1 × 1</caption>\n",
              "<thead>\n",
              "\t<tr><th scope=col>stat</th></tr>\n",
              "\t<tr><th scope=col>&lt;dbl&gt;</th></tr>\n",
              "</thead>\n",
              "<tbody>\n",
              "\t<tr><td>0.1612903</td></tr>\n",
              "</tbody>\n",
              "</table>\n"
            ],
            "text/markdown": "\nA infer: 1 × 1\n\n| stat &lt;dbl&gt; |\n|---|\n| 0.1612903 |\n\n",
            "text/latex": "A infer: 1 × 1\n\\begin{tabular}{l}\n stat\\\\\n <dbl>\\\\\n\\hline\n\t 0.1612903\\\\\n\\end{tabular}\n",
            "text/plain": [
              "  stat     \n",
              "1 0.1612903"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [],
      "metadata": {
        "id": "22UKMTHmOWIo"
      },
      "id": "22UKMTHmOWIo"
    },
    {
      "cell_type": "markdown",
      "source": [
        "Table : Observed Difference in Proportions"
      ],
      "metadata": {
        "id": "P1slae0-OAVI"
      },
      "id": "P1slae0-OAVI"
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Visualizing the p-value\n",
        "\n",
        "\n",
        "*   The final step is to visualize the p-value on the null distribution\n",
        "*   This means that if the null hypothesis holds true, how surprised would we be to see a difference in mortality rates of 16.13%?\n",
        "*   We accomplish this by first visualizing the null distribution using the  function ```visualize()``` function of infer package, and then we shall use ```shade_p_value``` function and set ```obs_stat``` to ```obs_diff_prop``` and we will set the ```direction = \"right\"``` because our alternative hypothesis is \"more extreme\" than the hypothesized world.\n",
        "\n"
      ],
      "metadata": {
        "id": "aBVrWYOWOhYr"
      },
      "id": "aBVrWYOWOhYr"
    },
    {
      "cell_type": "code",
      "source": [
        "# set the size of the plot (optional)\n",
        "\n",
        "options(repr.plot.width = 10, repr.plot.height = 8)\n",
        "visualize(null_distribution) +\n",
        "         shade_p_value(obs_stat = obs_diff_prop, direction = \"right\")"
      ],
      "metadata": {
        "id": "M8j95UKSPm0c",
        "outputId": "addadcd6-7ead-4020-d694-9ff7d94ce04f",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 497
        }
      },
      "id": "M8j95UKSPm0c",
      "execution_count": 30,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "plot without title"
            ],
            "image/png": "iVBORw0KGgoAAAANSUhEUgAABLAAAAPACAIAAACqxhfXAAAACXBIWXMAABJ0AAASdAHeZh94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\nghKEAAAAQQlCAACAoP4Hj5jXLb/+1VUAAAAASUVORK5CYII="
          },
          "metadata": {
            "image/png": {
              "width": 600,
              "height": 480
            }
          }
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "\n",
        "\n",
        "*   After visualizing the p-value on the null distribution, we can tell that there are chances that we will see a difference in the survival rates of 16.13% in a hypothesized worlf of no difference in the mortality rates between the two groups.\n",
        "*   Therefore, we would fail to reject the null hypothesis, in statistical terminology - \"Do not reject $H_0$\".\n",
        "\n"
      ],
      "metadata": {
        "id": "GTm_MWP-Qbde"
      },
      "id": "GTm_MWP-Qbde"
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Computing the p-value\n",
        "\n",
        "\n",
        "*   We shall compute the p-value using ```get_p_value``` function with ```obs_stat = obs_diff_prop``` and ```direction = \"right\"```.  \n",
        "\n"
      ],
      "metadata": {
        "id": "T_4C-SwfRVeS"
      },
      "id": "T_4C-SwfRVeS"
    },
    {
      "cell_type": "code",
      "source": [
        "null_distribution |>\n",
        "                   get_p_value(obs_stat = obs_diff_prop, direction = \"right\")"
      ],
      "metadata": {
        "id": "X_BRXL3kR2sS",
        "outputId": "8258288c-35cd-4fd6-b1ea-7c54adf383e6",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 147
        }
      },
      "id": "X_BRXL3kR2sS",
      "execution_count": 31,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/html": [
              "<table class=\"dataframe\">\n",
              "<caption>A tibble: 1 × 1</caption>\n",
              "<thead>\n",
              "\t<tr><th scope=col>p_value</th></tr>\n",
              "\t<tr><th scope=col>&lt;dbl&gt;</th></tr>\n",
              "</thead>\n",
              "<tbody>\n",
              "\t<tr><td>0.129</td></tr>\n",
              "</tbody>\n",
              "</table>\n"
            ],
            "text/markdown": "\nA tibble: 1 × 1\n\n| p_value &lt;dbl&gt; |\n|---|\n| 0.129 |\n\n",
            "text/latex": "A tibble: 1 × 1\n\\begin{tabular}{l}\n p\\_value\\\\\n <dbl>\\\\\n\\hline\n\t 0.129\\\\\n\\end{tabular}\n",
            "text/plain": [
              "  p_value\n",
              "1 0.129  "
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "\n",
        "\n",
        "*   This information indicates that there is a 12.9% probability of observing a mortality rate difference as substantial as 16.13% between individuals treated with D-penicillamine, distinguishing between those with and without ascites, solely due to random sampling fluctuations in a null distribution.\n",
        "*   Since the p-value is larger than our pre-specified significance level of 0.05, we fail to reject the null hypothesis.\n",
        "\n"
      ],
      "metadata": {
        "id": "uk9Kvel9SJ43"
      },
      "id": "uk9Kvel9SJ43"
    },
    {
      "cell_type": "markdown",
      "id": "509b1f44-54e0-423e-9b67-8e78e2a35af9",
      "metadata": {
        "id": "509b1f44-54e0-423e-9b67-8e78e2a35af9"
      },
      "source": [
        "## References\n"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "e1e12640-7fbe-49f5-ae73-4b23d3c9ebd8",
      "metadata": {
        "id": "e1e12640-7fbe-49f5-ae73-4b23d3c9ebd8"
      },
      "source": [
        "Prince, M., Chetwynd, A., Newman, W., Metcalf, J. V., &amp; James, O. F. W. (2002). Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years. Gastroenterology, 123(4), 1044–1051. __https://doi.org/10.1053/gast.2002.36027__\n",
        "\n",
        "Purohit, T. (2015). Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World Journal of Hepatology, 7(7), 926. __https://doi.org/10.4254/wjh.v7.i7.926__\n",
        "\n",
        "Dickson,E., Grambsch,P., Fleming,T., Fisher,L., and Langworthy,A.. (2023). Cirrhosis Patient Survival Prediction. UCI Machine Learning Repository. __https://doi.org/10.24432/C5R02G.__"
      ]
    }
  ],
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "display_name": "R",
      "language": "R",
      "name": "ir"
    },
    "language_info": {
      "codemirror_mode": "r",
      "file_extension": ".r",
      "mimetype": "text/x-r-source",
      "name": "R",
      "pygments_lexer": "r",
      "version": "4.2.2"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 5
}